TABLE 1.
Characteristics of the population in untargeted metabolomics analysis groups.
| Characteristics | SPs (n = 33) | VPs (n = 32) | P |
| Age, y | 56.58 (10.52) | 60.19 (10.49) | 0.252 |
| Male Sex, n (%) | 22 (66.7) | 23 (71.9) | 0.629 |
| Height, cm | 162.88 (8.24) | 161.69 (7.60) | 0.832 |
| Weight, kg | 68.33 (12.27) | 62.97 (9.45) | 0.165 |
| Smoking, n (%) | 9(27.3) | 13 (40.6) | 0.512 |
| Drinking, n (%) | 2 (6.1) | 4 (12.5) | 0.668 |
| Hypertension, n (%) | 20 (60.6) | 24 (75.0) | 0.463 |
| Diabetes, n (%) | 8 (24.2) | 9 (28.1) | 0.918 |
| CREA μmol/L | 77.48 (17.61) | 92.06 (32.70) | 0.064 |
| URIC μmol/L | 385.27 (90.27) | 405.91 (135.69) | 0.48 |
| TCHO mmol/L | 4.40 (0.90) | 4.40 (1.10) | 0.734 |
| TG mmol/L | 1.80 (1.28) | 1.81 (1.15) | 0.5 |
| HDLC mmol/L | 1.14 (0.36) | 1.11 (0.24) | 0.773 |
| LDLC mmol/L | 3.00 (1.52) | 3.06 (0.86) | 0.734 |
| EF (%) | 63.27 (7.87) | 64.66 (6.52) | 0.42 |
| Plaque (%) | > 0.001 | ||
| 0 | 33 (100.0) | 0 (0.0) | |
| 1 | 0 (0.0) | 32 (100.0) | |
| NA | 0 (0.0) | 0 (0.0) | |
| Lesion (%) | > 0.001 | ||
| 0 | 2 (6.1) | 6 (18.8) | |
| 1 | 23 (69.7) | 18 (56.2) | |
| 2 | 4 (12.1) | 5 (15.6) | |
| 3 | 4 (12.1) | 3 (9.4) | |
| NA | 0 (0.0) | 0 (0.0) | |
SP, stable plaque; VP, vulnerable plaque; HC, healthy control; CREA, creatinine; URIC, uric acid; TCHO, total cholesterol; TG, triglyceride; HDLC, high-density lipoprotein cholesterol; LDLC; low-density lipoprotein cholesterol; EF, ejection fraction. Continuous variables are presented as mean (SD). Categorical variables are presented as n (%). The bold values of Plaque (%) and lesion (%) mean the plaque and lesion are only two different factors in SP and VP groups.